CaixaBank, S.A.’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$836K Hold
4,690
– – ﹤0.01% 345
2026
Q2
$702K Buy
4,690
+1,104
+31% +$120K ﹤0.01% 347
2026
Q1
$331K Buy
+3,586
New +$360K ﹤0.01% 380
2021
Q4
– Sell
-5,892
Closed -$736K – 540
2021
Q3
$736K Sell
5,892
-492
-8% -$58.5K 0.01% 350
2021
Q2
$792K Sell
6,384
-2,284
-26% -$307K 0.01% 334
2021
Q1
$1.32M Buy
8,668
+2,256
+35% +$341K 0.01% 290
2020
Q4
$828K Buy
+6,412
New +$738K 0.01% 302

Other funds holding GH

CaixaBank, S.A.'s GH Position: Q3 2026 in Review

CaixaBank, S.A. held its Guardant Health (GH) position steady in Q3 2026 at 4,690 shares worth $836K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

CaixaBank, S.A. first reported a position in GH in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.32M in Q1 2021. 676 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • CaixaBank, S.A. held 4,690 shares of Guardant Health worth $836K as of Q3 2026.
  • CaixaBank, S.A. left its Guardant Health share count unchanged in Q3 2026.
  • Guardant Health made up ﹤0.01% of CaixaBank, S.A.'s portfolio in Q3 2026, its #345 holding.
  • CaixaBank, S.A. first reported a position in Guardant Health in Q4 2020 and has held it in 7 quarters since.
  • CaixaBank, S.A.'s Guardant Health position peaked at $1.32M in Q1 2021.
  • 676 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.